B. Given Douglas's most recent trade in Arrowhead Pharmaceuticals Inc. was a trade of 5,000 Common Stock done at an average price of $21.9 . Disclosure was reported to the exchange on Dec. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arrowhead Pharma Inc | B. Douglas Given | Director | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 16 Dec 2024 | 5,000 | 124,714 (0%) | 0% | 21.9 | 109,500 | Common Stock |
| Arrowhead Pharma Inc | B. Given Douglas | Director | Sale of securities on an exchange or to another person at price $ 22.04 per share. | 16 Dec 2024 | 547 | 124,167 (0%) | 0% | 22.0 | 12,056 | Common Stock |
| Arrowhead Pharma Inc | Douglas B. Given | Director | Sale of securities on an exchange or to another person at price $ 37.76 per share. | 11 Jan 2024 | 1,811 | 130,811 (0%) | 0% | 37.8 | 68,383 | Common Stock |
| Arrowhead Pharma Inc | B. Given Douglas | Director | Sale of securities on an exchange or to another person at price $ 38.55 per share. | 11 Jan 2024 | 1,100 | 129,711 (0%) | 0% | 38.6 | 42,405 | Common Stock |
| Arrowhead Pharma Inc | B. Given Douglas | Director | Grant, award, or other acquisition of securities at price $ 25.41 per share. | 15 Dec 2023 | 14,987 | 132,622 (0%) | 0% | 25.4 | 380,820 | Common Stock |
| Arrowhead Pharma Inc | Douglas B. Given | Director | Sale of securities on an exchange or to another person at price $ 40.90 per share. | 05 May 2023 | 6,500 | 117,635 (0%) | 0% | 40.9 | 265,850 | Common Stock |
| Arrowhead Pharma Inc | Douglas B. Given | Director | Sale of securities on an exchange or to another person at price $ 32.62 per share. | 27 Feb 2023 | 875 | 13,000 (0%) | 0% | 32.6 | 28,543 | Common Stock |
| Arrowhead Pharma Inc | Douglas B. Given | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 7,867 | 124,135 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Douglas B. Given | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 4,593 | 4,593 | - | - | Common Stock | |
| Arrowhead Pharma Inc | Douglas B. Given | Director | Purchase of securities on an exchange or from another person at price $ 66.37 per share. | 28 Dec 2021 | 655 | 109,868 (0%) | 0% | 66.4 | 43,472 | Common Stock |
| Arrowhead Pharma Inc | Douglas B. Given | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2021 | 655 | 109,213 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Douglas B. Given | Director | Sale of securities on an exchange or to another person at price $ 65.24 per share. | 09 Sep 2021 | 5,000 | 109,868 (0%) | 0% | 65.2 | 326,200 | Common Stock |
| Arrowhead Pharma Inc | Douglas B. Given | Director | Sale of securities on an exchange or to another person at price $ 89.21 per share. | 22 Jun 2021 | 4,500 | 114,868 (0%) | 0% | 89.2 | 401,445 | Common Stock |